Ayala Pharmaceuticals ROIC
Cos'è ROIC di Ayala Pharmaceuticals?
ROIC di Ayala Pharmaceuticals Inc. è -39.36%
Qual è la definizione di ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC di aziende nel Health Care settore su NASDAQ rispetto a Ayala Pharmaceuticals
Cosa fa Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Aziende con roic simili a Ayala Pharmaceuticals
- Oncimmune plc ha ROIC di -39.49%
- China Rapid Finance ha ROIC di -39.48%
- Jiu Zun Digital Interactive Entertainment ha ROIC di -39.41%
- Livehire ha ROIC di -39.38%
- Codexis ha ROIC di -39.37%
- Unity Biotechnology Inc ha ROIC di -39.37%
- Ayala Pharmaceuticals ha ROIC di -39.36%
- Cranstown Capital ha ROIC di -39.34%
- Copper Lake Resources ha ROIC di -39.32%
- Aclaris Therapeutics Inc ha ROIC di -39.31%
- Planet Green Corp ha ROIC di -39.31%
- Silence Therapeutics Plc ha ROIC di -39.30%
- Workhorse ha ROIC di -39.30%